Serap Sankoh

67 papers receiving 6.5k citations

Serap Sankoh's Hit Papers

The safety of vedolizumab for ulcerative colitis and Crohn's disease 2016 · 563 citations
5630+4+8Years since publication50010001.5k2.0k

Peers

Serap Sankoh
Comparison fields: 5 of 104
  • Genetics 4.8k
  • Epidemiology 3.8k
  • Immunology 2.1k
  • Gastroenterology 374
  • Virology 186
Replace Audrey J. Lazenby with:
Audrey J. Lazenby United States
Milan Lukáš Czechia
Maria Rosario United States
Niels Vande Casteele United States
Filip Baert Belgium
Roger W. Chapman United Kingdom
Kiron M. Das United States
Douglas C. Wolf United States
Mario Cottone Italy
Jean Yves Mary France
Serap Sankoh relative to Audrey J. Lazenby United States Audrey J. Lazenby's profile →
Citations per field
00.5×10×
Audrey J. Lazenby · 1×
Citations per year

Countries citing papers authored by Serap Sankoh

Since Specialization
Citations

This map shows the geographic impact of Serap Sankoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serap Sankoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serap Sankoh more than expected).

Fields of papers citing papers by Serap Sankoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serap Sankoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serap Sankoh. The network helps show where Serap Sankoh may publish in the future.

Co-authors

The 25 scholars most cited alongside Serap Sankoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Serap Sankoh Line = papers co-authored together Serap Sankoh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Hit paper breakdown →
20132048
2
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Hit paper breakdown →
20132011
3
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Hit paper breakdown →
2016563
4 2005203
5 2008195
6 2011182
7 2016168
8 2016167
9 2016158
10 2014134
11 2017126
12 202083
13 201776
14 200562
15 200539
16 201638
17 201931
18 201231
19 201722
20 201320

About Serap Sankoh

Serap Sankoh is a scholar working on Genetics, Epidemiology, Immunology, Oncology and Molecular Biology, having authored 67 papers that have together received 6.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (31 papers), Histone Deacetylase Inhibitors Research (10 papers), Biosimilars and Bioanalytical Methods (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Eosinophilic Esophagitis (5 papers), Celiac Disease Research and Management (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Genetics (4.8k citations), Epidemiology (3.8k citations), Immunology (2.1k citations), Gastroenterology (374 citations) and Virology (186 citations). Serap Sankoh has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Brian G. Feagan, Asit Parikh, Irving H. Fox, Bruce E. Sands, William J. Sandborn, Jean‐Frédéric Colombel, Catherine Milch, Paul Rutgeerts, Jing Xu and Silvio Danese. Their work appears in journals such as Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Gastroenterology, Journal of Clinical Oncology and Inflammatory Bowel Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact